FDA approves saliva-based coronavirus test viewed as 'major game changer'

The Food and Drug Administration on Saturday issued an emergency use authorization for the SalivaDirect COVID-19 diagnostic test developed by the Yale School of Public Health.
The test, which processes saliva samples to rapidly determine whether a person is infected with the coronavirus and does not require any type of swab or specific collection device, could be one of the first "major game changers in fighting the pandemic," said Andy Slavitt, a former acting administrator of the Centers for Medicare and Medicaid Services under the Obama administration, in a Twitter thread.
For starters, the process should be a lot more comfortable for people. It doesn't, as Slavitt puts it, require sticking "something four inches up a kid's nostril." But besides being painless, it's affordable — the materials are about $4, Slavitt said, and even when adding the cost of labor and overhead, its development is still cheaper than current tests.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
And, because it's cheap and has a fast turnaround time, people will likely be able to get tested more frequently, which will in turn increase diagnostic accuracy.
Slavitt believes all of these assets could especially come in handy for schools, universities, and office buildings which theoretically need to ramp up testing if they want to re-open safely. It could also encourage more asymptomatic people to get tested.
The final reason Slavitt has high praise for the test isn't about the science. Instead, he pointed out that Yale, in partnership with the NBA, developed the test without any intention of making a profit. Tim O'Donnell
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
How Canadian tariffs could impact tourism to the US
In the Spotlight Canadians represent the largest group of foreign visitors to the United States. But they may soon stop visiting.
By Justin Klawans, The Week US Published
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
The Week contest: Amazon Bond
Puzzles and Quizzes
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published